Primary Site >> Colorectal Cancer

Gene >> TET2

  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
PMID: 22320381
Ref: Recurrent R-spondin fusions in colon cancer.
PMID: 22895193
Ref: The CpG island methylator phenotype: what's in a name?
PMID: 23801749
Ref: Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2, -2B and SPANX-B, during mesenchymal-to-epithelial transition.
PMID: 25229454
Ref: TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
PMID: 25362856
Ref: Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.
PMID: 25557833
Ref: 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer.
PMID: 25853800
Ref: Loss of nuclear localization of TET2 in colorectal cancer.
PMID: 26816554
Ref: Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
PMID: 28524162
Ref: The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.
PMID: 28675510
Ref: Decrease in Lymphoid Specific Helicase and 5-hydroxymethylcytosine Is Associated with Metastasis and Genome Instability.
PMID: 29109788
Ref: Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
PMID: 29641532
Ref: Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease.
PMID: 29875879
Ref: STAT5 and TET2 Cooperate to Regulate FOXP3-TSDR Demethylation in CD4(+) T Cells of Patients with Colorectal Cancer.
PMID: 30013992